Technical Analysis for AMPH - Amphastar Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 20.14 -0.64% -0.13
AMPH closed down 0.64 percent on Friday, August 7, 2020, on 84 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical AMPH trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish -0.64%
Fell Below 50 DMA Bearish -0.64%
MACD Bearish Centerline Cross Bearish -0.64%
MACD Bearish Signal Line Cross Bearish -0.64%
Expansion Pivot Sell Setup Bearish Swing Setup -0.64%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Amphastar Pharmaceuticals, Inc., a generic and specialty pharmaceutical company, engages in the discovery, development, manufacture, and marketing of generic and proprietary pharmaceuticals, delivery systems, and active pharmaceutical ingredients. The company focuses on injectable, inhalation, and other categories of pharmaceutical products. Its products include Enoxaparin Sodium Injection, which is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis; Amphadase, a protein enzyme that is prepared from a highly purified bovine testicular hyaluronidase; Cortrosyn for Injection, a diagnostic agent that is used in the screening of patients presumed to have adrenocortocal insufficiency; and prefilled disposable emergency syringes for crash cart use. The company's products also include Lidocaine HCl Jelly, a preservative-free topical local anesthetic agent that is provided in a prefilled syringe; Naloxone HCl Injection for the complete or partial reversal of narcotic depression and diagnosis of suspected acute opioid overdose; and Phytonadione Injection (Vitamin K1) for newborns. In addition, it markets its drug development pipeline and patented technologies. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California with manufacturing subsidiaries/facilities in South El Monte, California; and West Roxbury and Canton, Massachusetts.
Medicine Chemistry Pharmaceutical Pharmaceutical Products Pharmacology Drug Development Medical Equipment Active Pharmaceutical Ingredients Syringe Deep Vein Thrombosis Drug Paraphernalia Injection Heroin Hyaluronidase Lidocaine Pulmonary Embolism

Is AMPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 22.85
52 Week Low 12.325
Average Volume 306,404
200-Day Moving Average 18.51
50-Day Moving Average 20.56
20-Day Moving Average 20.49
10-Day Moving Average 20.39
Average True Range 0.70
ADX 16.17
+DI 16.72
-DI 21.52
Chandelier Exit (Long, 3 ATRs ) 19.34
Chandelier Exit (Short, 3 ATRs ) 21.62
Upper Bollinger Band 21.34
Lower Bollinger Band 19.64
Percent B (%b) 0.3
BandWidth 8.31
MACD Line -0.05
MACD Signal Line -0.02
MACD Histogram -0.0317
Fundamentals Value
Market Cap 930.37 Million
Num Shares 46.2 Million
EPS 0.08
Price-to-Earnings (P/E) Ratio 251.75
Price-to-Sales 3.41
Price-to-Book 2.55
PEG Ratio 2.73
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.52
Resistance 3 (R3) 21.47 20.95 21.29
Resistance 2 (R2) 20.95 20.60 20.98 21.21
Resistance 1 (R1) 20.55 20.38 20.75 20.60 21.14
Pivot Point 20.03 20.03 20.14 20.06 20.03
Support 1 (S1) 19.63 19.68 19.83 19.68 19.14
Support 2 (S2) 19.11 19.46 19.14 19.07
Support 3 (S3) 18.71 19.11 18.99
Support 4 (S4) 18.76